Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, Wright M, Chiaramonte M, Graves M, Thomas HC, Hill AV, Thursz MR.

Genes Immun. 2003 Sep;4(6):411-9.

PMID:
12944978
2.

Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy.

Luo S, Cassidy W, Jeffers L, Reddy KR, Bruno C, Howell CD.

Clin Gastroenterol Hepatol. 2005 May;3(5):499-506.

PMID:
15880320
3.

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.

Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, Miki D, Mitsui F, Hiraga N, Imamura M, Takahashi S, Kubo M, Nakamura Y, Chayama K.

J Hepatol. 2011 Jun;54(6):1094-101. doi: 10.1016/j.jhep.2010.09.019. Epub 2011 Feb 4.

PMID:
21145800
4.

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

de Lucas S, Bartolome J, Carreno V.

J Infect Dis. 2005 Jan 1;191(1):93-9. Epub 2004 Nov 29.

PMID:
15593009
5.

IL-29 and IFN-α regulate the expression of MxA, 2',5'-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells.

Chai Y, Huang HL, Hu DJ, Luo X, Tao QS, Zhang XL, Zhang SQ.

Mol Biol Rep. 2011 Jan;38(1):139-43. doi: 10.1007/s11033-010-0087-1. Epub 2010 Mar 23.

PMID:
20309637
6.

Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population.

Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Ha LD, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T, Keicho N.

Biochem Biophys Res Commun. 2005 Apr 22;329(4):1234-9.

PMID:
15766558
7.

[Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].

Hu CH, Chen J, Yang R, Li NN, Yang B, Ma D, Liang XC, Wang Q.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Dec;28(12):1307-10. Chinese.

PMID:
23232524
8.

Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.

MacQuillan GC, Mamotte C, Reed WD, Jeffrey GP, Allan JE.

J Med Virol. 2003 Jun;70(2):219-27.

PMID:
12696108
9.

Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.

Wietzke-Braun P, Maouzi AB, Mänhardt LB, Bickeböller H, Ramadori G, Mihm S.

Eur J Gastroenterol Hepatol. 2006 Sep;18(9):991-7.

PMID:
16894313
10.

Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.

He J, Feng D, de Vlas SJ, Wang H, Fontanet A, Zhang P, Plancoulaine S, Tang F, Zhan L, Yang H, Wang T, Richardus JH, Habbema JD, Cao W.

BMC Infect Dis. 2006 Jul 6;6:106.

11.

Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.

Hamdi N, El-Akel W, El-Serafy M, Esmat G, Sarrazin C, Abdelaziz AI.

Intervirology. 2012;55(3):210-8. doi: 10.1159/000327783. Epub 2011 May 20.

12.

[Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].

Huang YX, Ma LN, Chen XY, Li Z, Huang YL, Shen CL, Ma B.

Zhonghua Gan Zang Bing Za Zhi. 2007 Mar;15(3):187-91. Chinese.

PMID:
17407708
13.

Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.

Bader El Din NG, Salum GM, Anany MA, Ibrahim MK, Dawood RM, Zayed N, El Abd YS, El-Shenawy R, El Awady MK.

J Interferon Cytokine Res. 2015 Aug;35(8):641-8. doi: 10.1089/jir.2014.0137. Epub 2015 Apr 13.

PMID:
25868067
14.

Two novel SNPs in the promoter region of PKR gene in hepatitis C patients and their impact on disease outcome and response to treatment.

El-Dahshan D, Bahy D, Wahid A, Ahmed AE, Hanora A.

Arab J Gastroenterol. 2018 Sep;19(3):106-115. doi: 10.1016/j.ajg.2018.06.002. Epub 2018 Sep 20.

PMID:
30245117
15.

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

Vlotides G, Sörensen AS, Kopp F, Zitzmann K, Cengic N, Brand S, Zachoval R, Auernhammer CJ.

Biochem Biophys Res Commun. 2004 Jul 30;320(3):1007-14.

PMID:
15240148
16.

Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.

Suzuki F, Arase Y, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Takagi K, Satoh J, Kumada H.

J Viral Hepat. 2004 May;11(3):271-6.

PMID:
15117331
17.

MxA and PKR expression in chronic hepatitis C.

Giannelli G, Guadagnino G, Dentico P, Antonelli G, Antonaci S.

J Interferon Cytokine Res. 2004 Nov;24(11):659-63.

PMID:
15684819
18.

Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.

MacQuillan GC, de Boer WB, Platten MA, McCaul KA, Reed WD, Jeffrey GP, Allan JE.

J Med Virol. 2002 Oct;68(2):197-205.

PMID:
12210408
19.

MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.

Kong XF, Zhang XX, Gong QM, Gao J, Zhang SY, Wang L, Xu J, Han Y, Jin GD, Jiang JH, Zhang DH, Lu ZM.

J Interferon Cytokine Res. 2007 Sep;27(9):809-18.

PMID:
17892402
20.

Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

Dansako H, Naganuma A, Nakamura T, Ikeda F, Nozaki A, Kato N.

Virus Res. 2003 Nov;97(1):17-30.

PMID:
14550584

Supplemental Content

Support Center